|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-3-31
|
|
pubmed:abstractText |
The lack of accurate criteria to predict the response to radiotherapy for individual patients with squamous cell carcinoma of the head and neck (HN-SCC) remains a major problem. The purpose of this study was to investigate the role of several biologic tumor markers to complement clinical prognostic factors in the assessment of response to radiotherapy in SCCs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1030-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:9060543-Adult,
pubmed-meshheading:9060543-Aged,
pubmed-meshheading:9060543-Aged, 80 and over,
pubmed-meshheading:9060543-Carcinoma, Squamous Cell,
pubmed-meshheading:9060543-Female,
pubmed-meshheading:9060543-Glutathione Transferase,
pubmed-meshheading:9060543-Head and Neck Neoplasms,
pubmed-meshheading:9060543-Humans,
pubmed-meshheading:9060543-Ki-67 Antigen,
pubmed-meshheading:9060543-Male,
pubmed-meshheading:9060543-Middle Aged,
pubmed-meshheading:9060543-Multivariate Analysis,
pubmed-meshheading:9060543-Neoplasm Staging,
pubmed-meshheading:9060543-Radiation Tolerance,
pubmed-meshheading:9060543-Radiotherapy Dosage,
pubmed-meshheading:9060543-Receptor, erbB-2,
pubmed-meshheading:9060543-Tumor Markers, Biological,
pubmed-meshheading:9060543-Tumor Suppressor Protein p53
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
|
|
pubmed:affiliation |
Department of Pathology, Faculté de Médicine, Université Laval, Québec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
